Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant

BACKGROUND: Extended first‐line therapy (1LT) has improved clinical outcomes in newly diagnosed multiple myeloma (NDMM). This retrospective study of NDMM patients evaluated the relationship between dose‐attenuation of 1LT and duration of therapy (DOT) and DOT on outcomes. METHODS: Adults with NDMM n...

Descripción completa

Detalles Bibliográficos
Autores principales: Ailawadhi, Sikander, Ogbonnaya, Augustina, Murty, Sharanya, Cherepanov, Dasha, Schroader, Bridgette Kanz, Romanus, Dorothy, Farrelly, Eileen, Chari, Ajai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939178/
https://www.ncbi.nlm.nih.gov/pubmed/36151787
http://dx.doi.org/10.1002/cam4.5239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939178/
https://www.ncbi.nlm.nih.gov/pubmed/36151787
http://dx.doi.org/10.1002/cam4.5239

Ejemplares similares